Dillon & Associates’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,749
| Closed | -$240K | – | 80 |
|
|
2023
Q3 | $240K | Sell |
7,749
-7,204
| -48% | -$223K | 0.05% | 74 |
|
|
2023
Q2 | $598K | Sell |
14,953
-26,735
| -64% | -$1.07M | 0.11% | 59 |
|
|
2023
Q1 | $1.71M | Sell |
41,688
-230
| -0.5% | -$9.43K | 0.34% | 46 |
|
|
2022
Q4 | $1.64M | Sell |
41,918
-1,460
| -3% | -$56.9K | 0.35% | 48 |
|
|
2022
Q3 | $2.3M | Buy |
43,378
+11,534
| +36% | +$611K | 0.53% | 40 |
|
|
2022
Q2 | $1.85M | Buy |
31,844
+28,759
| +932% | +$1.67M | 0.42% | 41 |
|
|
2022
Q1 | $234K | Buy |
+3,085
| New | +$234K | 0.04% | 72 |
|